期刊文献+

fgl2凝血酶原酶多肽抗体的制备和应用 被引量:2

Preparation and application of fgl2 prothrombinase peptide antibody
原文传递
导出
摘要 目的 利用人工合成多肽制备针对人源、鼠源fgl2凝血酶原酶 (hfgl2、mfgl2 )的特异性多克隆抗体 ,以期用于与fgl2表达异常密切相关的疾病的研究和诊治。方法 根据mfgl2、hfgl2基因编码的氨基酸序列合成多肽 3(Pep3)和多肽 4 (Pep4 ) ,并用化学方法与匙孔血蓝蛋白 (KLH)连接 ,纯品Pep3 KLH和Pep4 KLH免疫动物 ,所制备的抗血清用ELISA、Westernblot和前凝血质活性 (PCA)实验鉴定 ,并采用免疫组化法应用于乙型肝炎患者肝组织中hfgl2的检测。结果 ELISA检测表明 ,所制备的抗血清可分别与Pep3和Pep4发生特异性免疫反应 ;Westernblot结果显示 ,抗血清可识别MHV 3感染BALB cJ小鼠腹腔巨噬细胞特异性条带 ,相对分子质量 (Mr)为 6 5× 10 3;PCA实验提示 ,抗血清具有中和mfgl2分子酶活性的作用。对病毒性乙型肝炎患者肝组织免疫组织化学染色发现hfgl2仅在重型乙型肝炎患者高表达 ,而在慢性乙型肝炎和肝硬化患者的肝组织中无表达。结论 所制备的fgl2的多肽抗体 (多克隆抗体 )可识别mfgl2和hfgl2分子 ,具有与抗原特异性结合、中和其酶活性的特征 ,为深入研究这一新发现的分子提供了有力的科学手段。 ObjectiveTo prepare a peptide polyclonal antibody against both murine and human fgl2 prothrombinase/fibroleukin based on the chemically synthesized peptide 3 (Pep3) and peptide 4 (Pep4) from exon 1 and 2 of the predicted amino acid sequence of mfgl2 protein separately. MethodsThe Pep3 and Pep4 were coupled to keyhole limpet hemocyanin (KLH) to form a complex of Pep3-KLH and Pep4-KLH. The anti sera were developed by immunizing rabbit with Pep3-KLH or Pep4-KLH after emulsified in Freund′s complete adjuvant (FCA). The purified anti sera were also utilized to detect the hfgl2 expression in the liver tissue of hepatitis B patients. ResultsThe anti sera react with Pep3 and Pep4,and the titer around 1∶320 000 (Pep3) and 1∶160 000 (Pep4) respectively. Western blot displayed a specifically M_r (molecular mass relatively) 65 000 reactive band in murine hepatitis virus strain 3 infected macrophages from BALB/cJ mice when incubated with anti sera. PCA assay showed that the anti sera inhibited functional activity of mfgl2 prothrombinase expressed on the MHV-3 infected BALB/cJ macrophages in a dose-dependent fashion. The purified anti sera also recognized hfgl2 molecule highly expressed in liver tissue from patients with active acute on chronic hepatitis B. ConclusionPeptide polyclonal antibody against fgl2 prothrombinase was successfully raised with expected specificity,titers and neutralization activity. This study provided an important tool to explore the roles of this newly discovered molecule from human disease and animal model.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2004年第8期649-652,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目 (NSFC3 0 170 846) 国家杰出青年科学基金项目 (NSFC3 0 2 2 5 0 40 NSFC3 0 12 5 0 19) 国家高技术研究发展计划项目 (国科发财字 [2 0 0 2 ] 469号 )
关键词 fg12凝血酶原 酶多肽抗体 3型鼠肝炎病毒 纤维介素 Peptide Antibody Hepatitis MHV-3 fgl2/fibroleukin
  • 相关文献

参考文献9

  • 1Ding JW, Ning Q, Liu MF, et al. Fulminant hepatitis failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol, 1997, 71: 9223-9230.
  • 2Levy GA, Liu MF, Ding JW, et al. Molecular and analysis of the human prothrombinase gene(hfgl2) and its role in viral hepatitis. Am J Pathol, 2000, 156: 1217-1225.
  • 3Ruegg C, Pytela R. Sequence of a human transcript expressed in T lymphocyte and encoding a fibrinogen-like protein. Gene, 1995, 160: 257-262.
  • 4Ning Q, Chen Y, Zhu F, et al. Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its role in viral hepatitis. Hepatology, 2002, 36(4, suppl): 369A.
  • 5Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves TH1 cytokine production but inhibits TH2 cytokine response. J Immunol, 1998, 160: 3487-3493.
  • 6Fung LS, Neil G, Leibowitz J, et al. Monoclonal antibody analysis of a unique procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem, 1991, 266: 1789-1795.
  • 7Chan CW, Chan MW, Liu MF, et al. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol, 2002, 168: 5170-5177.
  • 8Ning Q, Lakatoo S, Liu M, et al. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4α. J Biol Chem, 2003, 278: 15541-15549.
  • 9Marsden PA, Ning Q, Fung LS, et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically-mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 2003, 112: 58-66.

同被引文献7

  • 1Ning Q, Brown D, Parodo Jet al. Ribavirin inhibits viral induced macrophage production of TNF, IL-1, the procoagulant fgl2/pmthrombinase and preserves TH1 cytokine production but inhibits TH2 cytokine response[ J]. J Immunol, 1998 ; 160 : 3487-3493.
  • 2Paris P L, Hofer M D, Albo Get al. Genomic profiling of hormone-naive lymph node etastases in patients with prostate cancer [ J]. Neoplasia, 2006;8(12) : 1083-1089.
  • 3Naylor T L, Greshock J, Wang Yet al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization[J]. Breast Cancer Res,2005;7(6):R1186-R1198.
  • 4Ning Q, Chen Y, Zhu F, et al. HFGL2 Fibroleukin expression in liver and peripheral blood mononuelear cells (PBMC)and its role in viral hepatitis[J]. Hepatology, 2002, 36(4):369.
  • 5孙奕,宁琴,龚非力.凝血酶与移植物内皮细胞损伤[J].中华器官移植杂志,2002,23(2):125-126. 被引量:7
  • 6孙奕,宁琴,李锦文,严伟明,陈忠华,龚非力.鼠纤维介素在小鼠心脏移植急性排斥反应中的表达及其意义[J].中华器官移植杂志,2003,24(5):294-297. 被引量:27
  • 7严卫丽,顾东风.复杂疾病关联研究中的若干问题[J].Acta Genetica Sinica,2004,31(5):533-537. 被引量:13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部